Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Lead

Memorial Sloan Kettering Cancer Center

With

• Genentech, Inc.
• Children's Mercy Hospital Kansas City
• Penn State University
• University of Colorado, Denver
• Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
• Phoenix Children's Hospital Center for Cancer & Blood Disorders
• Alberta Children's Hospital
• MD Anderson Cancer Center Orlando
• M.D. Anderson Cancer Center